DOLORES LOPEZ-TERRADA

Concepts (621)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hepatoblastoma
26
2025
179
5.710
Why?
Liver Neoplasms
36
2025
1318
5.050
Why?
Oncogene Proteins, Fusion
28
2025
213
3.570
Why?
Carcinoma, Hepatocellular
15
2025
933
2.620
Why?
Translocation, Genetic
21
2025
360
2.220
Why?
Dermatofibrosarcoma
9
2018
17
2.210
Why?
Gene Rearrangement
15
2014
322
2.160
Why?
Reverse Transcriptase Polymerase Chain Reaction
23
2015
1296
1.860
Why?
Biomarkers, Tumor
22
2024
1526
1.840
Why?
In Situ Hybridization, Fluorescence
28
2016
768
1.830
Why?
Soft Tissue Neoplasms
9
2014
121
1.820
Why?
Gene Fusion
6
2024
57
1.680
Why?
Skin Neoplasms
10
2020
862
1.270
Why?
Child
73
2025
24559
1.190
Why?
Calmodulin-Binding Proteins
6
2014
63
1.180
Why?
Immunohistochemistry
22
2017
1706
1.070
Why?
Sarcoma, Ewing
7
2013
110
1.050
Why?
Neoplasms
8
2025
2803
0.990
Why?
beta Catenin
7
2022
207
0.980
Why?
Adenomatous Polyposis Coli
2
2018
42
0.960
Why?
Humans
139
2025
125667
0.950
Why?
RNA-Binding Proteins
8
2014
576
0.940
Why?
Transcription Factors
15
2022
2604
0.920
Why?
Laboratory Proficiency Testing
1
2024
8
0.900
Why?
Neoplastic Syndromes, Hereditary
1
2025
73
0.890
Why?
Mutation
13
2022
5893
0.880
Why?
Sarcoma, Clear Cell
3
2009
20
0.860
Why?
Neoplasm Proteins
7
2019
676
0.860
Why?
High-Throughput Nucleotide Sequencing
6
2024
883
0.810
Why?
Adolescent
45
2024
19441
0.790
Why?
Child, Preschool
34
2025
14106
0.770
Why?
Liposarcoma, Myxoid
2
2011
3
0.730
Why?
Male
75
2024
61776
0.720
Why?
Bone Neoplasms
7
2018
427
0.720
Why?
Female
79
2024
66998
0.710
Why?
Neoplasm Transplantation
4
2017
383
0.700
Why?
Proto-Oncogene Proteins
7
2023
554
0.690
Why?
Sarcoma
5
2014
182
0.690
Why?
Trans-Activators
4
2015
800
0.680
Why?
Repressor Proteins
6
2025
817
0.680
Why?
Genetic Predisposition to Disease
6
2025
3174
0.670
Why?
Neovascularization, Pathologic
3
2017
241
0.670
Why?
Carcinoma, Mucoepidermoid
2
2015
13
0.650
Why?
Oncogene Fusion
4
2017
22
0.620
Why?
Biopsy
8
2021
1241
0.620
Why?
Infant
30
2025
12572
0.620
Why?
DNA, Neoplasm
10
2020
306
0.610
Why?
Neoplasms, Second Primary
2
2017
152
0.600
Why?
Proto-Oncogene Proteins B-raf
2
2017
193
0.590
Why?
Fibrosarcoma
3
2012
26
0.580
Why?
Molecular Diagnostic Techniques
3
2022
152
0.580
Why?
Liver Neoplasms, Experimental
1
2017
59
0.570
Why?
Young Adult
22
2021
9093
0.570
Why?
MAP Kinase Signaling System
2
2019
316
0.570
Why?
Genetic Testing
5
2024
1013
0.560
Why?
Fibromatosis, Aggressive
3
2012
8
0.560
Why?
Thyroid Neoplasms
2
2020
189
0.560
Why?
Chromosomes, Human, Pair 1
1
2017
140
0.550
Why?
Adult
46
2022
29734
0.540
Why?
Chromosomes, Human, Pair 6
1
2017
143
0.540
Why?
Genes, APC
2
2018
13
0.540
Why?
Chromosomes, Human, Pair 7
2
2019
74
0.540
Why?
Thrombocytosis
1
2017
34
0.540
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
2017
97
0.530
Why?
Phenotype
5
2017
4273
0.530
Why?
Antineoplastic Combined Chemotherapy Protocols
7
2021
1256
0.530
Why?
Chromosomes, Human, Pair 12
2
2016
92
0.520
Why?
Cholangiocarcinoma
1
2017
107
0.520
Why?
Liver
6
2023
1749
0.520
Why?
RNA-Binding Protein EWS
10
2014
33
0.510
Why?
Zinc Finger Protein GLI1
1
2016
35
0.510
Why?
Epithelioid Cells
3
2012
11
0.500
Why?
Liver Diseases
2
2019
368
0.500
Why?
Calcium-Binding Proteins
2
2015
326
0.500
Why?
Gene Expression Regulation, Neoplastic
13
2022
1962
0.500
Why?
Oncogenes
1
2016
174
0.500
Why?
Chromosomes, Human, Pair 17
4
2014
370
0.490
Why?
RNA-Binding Protein FUS
2
2012
13
0.490
Why?
Thyroid Nodule
1
2015
19
0.490
Why?
Neuroblastoma
2
2017
528
0.480
Why?
Salivary Gland Neoplasms
2
2015
55
0.480
Why?
Hemangioendothelioma, Epithelioid
1
2015
10
0.480
Why?
Mental Retardation, X-Linked
1
2015
71
0.470
Why?
Cauda Equina
1
2014
9
0.470
Why?
Carcinogenesis
2
2023
340
0.470
Why?
Peripheral Nervous System Neoplasms
1
2014
12
0.470
Why?
Cyclin B
1
2014
22
0.460
Why?
Neoplasm Recurrence, Local
8
2024
1160
0.460
Why?
Glomus Tumor
1
2014
13
0.460
Why?
WT1 Proteins
1
2014
27
0.460
Why?
Prognosis
13
2021
4690
0.460
Why?
Cell Line, Tumor
8
2024
3396
0.450
Why?
Proto-Oncogene Proteins c-sis
2
2012
19
0.440
Why?
Histiocytosis, Langerhans-Cell
1
2017
221
0.440
Why?
Sarcoma, Synovial
4
2021
21
0.430
Why?
Actins
1
2016
346
0.430
Why?
Intracellular Signaling Peptides and Proteins
3
2015
558
0.420
Why?
Collagen Type I
2
2012
112
0.420
Why?
Pathologists
2
2024
29
0.420
Why?
Receptor, Fibroblast Growth Factor, Type 1
2
2013
66
0.420
Why?
Chromosomes, Human, Pair 11
4
2013
87
0.420
Why?
Lymphoma, Large-Cell, Anaplastic
3
2022
46
0.420
Why?
Neuroectodermal Tumors, Primitive, Peripheral
3
2008
14
0.410
Why?
Carcinoma
1
2015
290
0.410
Why?
Methyl-CpG-Binding Protein 2
1
2015
310
0.410
Why?
Hodgkin Disease
2
2015
292
0.400
Why?
Neoplastic Cells, Circulating
2
2024
74
0.400
Why?
Receptor Protein-Tyrosine Kinases
3
2022
130
0.400
Why?
Thoracic Neoplasms
1
2012
38
0.400
Why?
DNA-Binding Proteins
4
2011
2054
0.400
Why?
Leukemia, Myeloid, Acute
2
2017
538
0.400
Why?
Myeloproliferative Disorders
2
2013
87
0.400
Why?
Thoracic Vertebrae
1
2012
68
0.390
Why?
Rhabdomyosarcoma, Alveolar
2
2009
36
0.390
Why?
Isochromosomes
1
2012
18
0.390
Why?
Spinal Neoplasms
1
2012
58
0.390
Why?
Cell Differentiation
4
2021
1912
0.390
Why?
Chromosome Aberrations
6
2020
620
0.380
Why?
Parotid Gland
1
2011
20
0.380
Why?
Chromosomes, Human, Pair 8
2
2024
79
0.380
Why?
Middle Aged
34
2024
27000
0.370
Why?
Vulvar Neoplasms
2
2008
18
0.370
Why?
Stem Cells
1
2016
711
0.370
Why?
Xenograft Model Antitumor Assays
5
2024
908
0.370
Why?
Lymphoma, Large B-Cell, Diffuse
2
2024
144
0.370
Why?
Cell Dedifferentiation
1
2010
21
0.350
Why?
Liposarcoma
1
2010
22
0.350
Why?
Simian virus 40
3
2008
199
0.350
Why?
Drug Screening Assays, Antitumor
1
2010
96
0.350
Why?
DNA Primers
2
2010
658
0.350
Why?
Stomach Neoplasms
2
2016
548
0.340
Why?
Chromosome Breakpoints
1
2010
81
0.340
Why?
Histiocytoma, Benign Fibrous
1
2010
12
0.340
Why?
Polyomavirus Infections
2
2008
90
0.340
Why?
Chimera
1
2010
83
0.340
Why?
Tumor Virus Infections
2
2008
135
0.340
Why?
Sequence Analysis, RNA
2
2024
372
0.330
Why?
Neoplasm Invasiveness
4
2017
623
0.330
Why?
SMARCB1 Protein
2
2020
38
0.320
Why?
Receptors, Cell Surface
1
2011
475
0.320
Why?
DNA Mutational Analysis
6
2015
800
0.320
Why?
Treatment Outcome
13
2023
12420
0.320
Why?
Pathology
1
2009
41
0.320
Why?
CREB-Binding Protein
1
2009
64
0.320
Why?
Heterografts
3
2024
176
0.310
Why?
Cell Transformation, Neoplastic
2
2011
630
0.310
Why?
Antigens, CD34
4
2012
109
0.310
Why?
Mice
14
2024
17727
0.310
Why?
Palatine Tonsil
2
2008
36
0.310
Why?
Wnt Proteins
2
2009
211
0.300
Why?
Neoplasm Staging
6
2021
1278
0.300
Why?
Chondrosarcoma
1
2008
11
0.300
Why?
Aged
20
2018
19900
0.300
Why?
Pharyngeal Diseases
1
2008
19
0.300
Why?
Cerebellar Neoplasms
1
2012
392
0.290
Why?
Genomics
5
2024
1516
0.290
Why?
Medulloblastoma
1
2012
477
0.280
Why?
Myofibroma
2
2017
9
0.280
Why?
Glioma
2
2022
513
0.270
Why?
Fasciitis
2
2017
19
0.270
Why?
Infant, Newborn
12
2024
8249
0.270
Why?
Algorithms
2
2022
1632
0.270
Why?
Tumor Suppressor Protein p53
5
2019
740
0.260
Why?
Real-Time Polymerase Chain Reaction
4
2016
509
0.260
Why?
Combined Modality Therapy
5
2021
1248
0.260
Why?
Immunophenotyping
3
2017
329
0.260
Why?
Sarcoma, Alveolar Soft Part
3
2012
10
0.250
Why?
Sequence Analysis, DNA
6
2022
1759
0.250
Why?
Animals
16
2024
34349
0.250
Why?
Intestinal Neoplasms
1
2006
40
0.250
Why?
Tumor Burden
2
2017
230
0.240
Why?
Risk Factors
9
2025
10340
0.240
Why?
Karyotyping
6
2016
324
0.240
Why?
Diagnosis, Differential
7
2024
1901
0.240
Why?
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
4
2015
177
0.240
Why?
Peutz-Jeghers Syndrome
1
2025
27
0.240
Why?
Fatal Outcome
5
2017
359
0.230
Why?
Base Sequence
9
2012
3108
0.230
Why?
Carcinoma, Renal Cell
2
2020
241
0.230
Why?
Core Binding Factor Alpha 2 Subunit
1
2025
39
0.230
Why?
Li-Fraumeni Syndrome
1
2025
46
0.230
Why?
Germ-Line Mutation
3
2018
342
0.230
Why?
Databases, Factual
3
2020
1186
0.230
Why?
Proto-Oncogene Proteins c-bcl-2
2
2024
173
0.230
Why?
Proto-Oncogene Proteins c-ets
1
2025
58
0.230
Why?
Glypicans
1
2024
39
0.230
Why?
Histiocytes
2
2017
23
0.230
Why?
Molecular Sequence Data
9
2012
3896
0.220
Why?
Interleukin-15
1
2024
93
0.220
Why?
Chromosomes, Human, Pair 22
6
2013
103
0.220
Why?
Indocyanine Green
1
2024
55
0.220
Why?
Molecular Biology
2
2011
80
0.220
Why?
Sensitivity and Specificity
2
2024
2060
0.210
Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
2025
128
0.210
Why?
Mice, SCID
2
2017
583
0.210
Why?
Disease-Free Survival
5
2020
907
0.210
Why?
Leukemia, Megakaryoblastic, Acute
1
2022
19
0.200
Why?
Rare Diseases
1
2024
190
0.200
Why?
Burkitt Lymphoma
1
2024
144
0.200
Why?
alpha-Fetoproteins
3
2023
131
0.200
Why?
Sclerosis
2
2012
34
0.200
Why?
Cytogenetic Analysis
3
2014
81
0.200
Why?
Neoplasm Grading
2
2014
278
0.200
Why?
Antigens, Polyomavirus Transforming
3
2008
88
0.190
Why?
Neutrophils
2
2001
381
0.190
Why?
Yttrium Radioisotopes
1
2021
18
0.190
Why?
Ki-67 Antigen
3
2024
114
0.190
Why?
Retrospective Studies
11
2023
16417
0.190
Why?
Skull Neoplasms
1
2001
14
0.190
Why?
Ki-1 Antigen
1
2001
28
0.180
Why?
Lymphatic Metastasis
3
2020
418
0.180
Why?
Tumor Cells, Cultured
5
2020
1072
0.180
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
2025
783
0.180
Why?
Osteosarcoma
3
2003
255
0.180
Why?
Fixatives
2
2012
14
0.180
Why?
Disease Models, Animal
4
2023
4409
0.180
Why?
Paraffin Embedding
2
2012
34
0.180
Why?
Formaldehyde
2
2012
36
0.180
Why?
Epstein-Barr Virus Infections
2
2022
294
0.170
Why?
Ubiquitin Thiolesterase
2
2017
61
0.170
Why?
Hospitals
1
2023
398
0.170
Why?
Carcinoma, Medullary
1
2020
15
0.170
Why?
Bone Marrow
3
2017
325
0.170
Why?
Hemangioma, Capillary
1
2020
17
0.170
Why?
Cell Cycle Proteins
3
2023
659
0.170
Why?
Carcinoma, Papillary
1
2020
71
0.170
Why?
Sarcoma, Myeloid
1
2019
12
0.160
Why?
Craniocerebral Trauma
1
2001
139
0.160
Why?
Exome
1
2024
1035
0.160
Why?
Proton Therapy
1
2021
125
0.160
Why?
DNA Copy Number Variations
2
2022
959
0.160
Why?
Leukocytosis
2
2017
46
0.160
Why?
Precursor Cells, B-Lymphoid
1
2019
15
0.160
Why?
Leukemia, Myelomonocytic, Juvenile
1
2019
9
0.160
Why?
Ependymoma
1
2021
164
0.160
Why?
Neoadjuvant Therapy
1
2021
343
0.160
Why?
Central Nervous System Neoplasms
1
2022
204
0.160
Why?
Azacitidine
1
2019
53
0.160
Why?
Tracheal Neoplasms
1
1999
20
0.160
Why?
Neuroectodermal Tumors, Primitive
2
1998
55
0.160
Why?
Neuroectodermal Tumors
1
1999
13
0.160
Why?
Embolization, Therapeutic
1
2021
223
0.160
Why?
Lymph Nodes
3
2017
379
0.160
Why?
Hemangioma
1
2020
93
0.160
Why?
Serine Endopeptidases
2
2018
181
0.150
Why?
Discoidin Domain Receptor 2
1
2018
5
0.150
Why?
Adamantinoma
1
2018
2
0.150
Why?
Survival Rate
4
2021
2073
0.150
Why?
Rhabdoid Tumor
1
2019
50
0.150
Why?
Proteostasis
1
2019
34
0.150
Why?
Postoperative Hemorrhage
1
2019
84
0.150
Why?
Carcinoma, Small Cell
1
2018
51
0.150
Why?
Non-alcoholic Fatty Liver Disease
1
2023
398
0.150
Why?
Gene Amplification
2
2013
234
0.150
Why?
Endoplasmic Reticulum Stress
1
2019
121
0.150
Why?
Immunotherapy, Adoptive
1
2024
832
0.150
Why?
DNA Replication
1
2020
356
0.150
Why?
Biopsy, Fine-Needle
4
2013
117
0.150
Why?
Promoter Regions, Genetic
3
2017
1337
0.140
Why?
Cooperative Behavior
2
2016
220
0.140
Why?
Hep G2 Cells
1
2017
85
0.140
Why?
Antimetabolites, Antineoplastic
1
2019
185
0.140
Why?
Chromosome Banding
1
2017
138
0.140
Why?
Forkhead Transcription Factors
3
2009
358
0.140
Why?
Follow-Up Studies
5
2021
5195
0.140
Why?
Mice, Inbred NOD
1
2017
299
0.140
Why?
Xanthogranuloma, Juvenile
1
2017
31
0.140
Why?
Microtubule-Associated Proteins
1
2018
246
0.140
Why?
Cell Nucleus
3
2012
679
0.140
Why?
Mitogen-Activated Protein Kinase 1
1
2017
111
0.130
Why?
Sarcoma, Small Cell
1
1996
1
0.130
Why?
Cytogenetics
1
1996
18
0.130
Why?
Monosomy
1
1996
24
0.130
Why?
Hepatocyte Nuclear Factor 3-alpha
1
2016
48
0.130
Why?
Tissue Array Analysis
4
2009
138
0.130
Why?
Liver Transplantation
3
2021
1039
0.130
Why?
Neoplasms, Glandular and Epithelial
1
2016
39
0.130
Why?
Myelodysplastic Syndromes
1
2017
139
0.130
Why?
Cohort Studies
5
2024
4843
0.130
Why?
T-Lymphocytes
1
2024
1727
0.130
Why?
Receptors, Purinergic P2X3
1
2015
3
0.130
Why?
Chromosome Mapping
3
2023
1083
0.130
Why?
Transcriptional Regulator ERG
2
2013
38
0.130
Why?
Nose Neoplasms
1
1996
32
0.120
Why?
Proto-Oncogene Proteins c-ret
1
2015
23
0.120
Why?
Transplantation Conditioning
1
2017
325
0.120
Why?
NF-E2-Related Factor 2
1
2016
114
0.120
Why?
Kidney Neoplasms
1
2020
440
0.120
Why?
Autophagy
1
2019
393
0.120
Why?
Interleukin-8
1
2016
209
0.120
Why?
Genes, Tumor Suppressor
1
2016
209
0.120
Why?
Ikaros Transcription Factor
1
2015
28
0.120
Why?
Integrases
1
2016
160
0.120
Why?
Ifosfamide
1
2015
32
0.120
Why?
Mutagenesis
1
2016
346
0.120
Why?
Vinblastine
1
2015
53
0.120
Why?
Herpesvirus 4, Human
4
2022
676
0.120
Why?
International Cooperation
1
2015
158
0.120
Why?
Boronic Acids
1
2015
46
0.120
Why?
Bortezomib
1
2015
70
0.120
Why?
Mitotic Index
1
2014
19
0.120
Why?
Recombination, Genetic
1
2016
448
0.120
Why?
Pyrazines
1
2015
73
0.120
Why?
Telomerase
1
2015
168
0.110
Why?
Neoplasms, Multiple Primary
3
2012
71
0.110
Why?
Ovarian Neoplasms
1
2018
419
0.110
Why?
Adaptor Proteins, Signal Transducing
2
2015
557
0.110
Why?
Diagnostic Errors
1
2018
334
0.110
Why?
Mice, Knockout
3
2019
3753
0.110
Why?
Risk
1
2016
758
0.110
Why?
Myeloid Cells
1
2014
102
0.110
Why?
Leukemia, Promyelocytic, Acute
1
2014
24
0.110
Why?
Neoplasm Metastasis
2
2020
702
0.110
Why?
Laparoscopy
1
2019
493
0.110
Why?
Polymerase Chain Reaction
5
2008
1590
0.110
Why?
Muir-Torre Syndrome
1
2013
1
0.110
Why?
Long Interspersed Nucleotide Elements
1
2013
32
0.110
Why?
Time Factors
5
2021
6351
0.110
Why?
Retroperitoneal Neoplasms
1
2013
30
0.100
Why?
Lymphoma, AIDS-Related
2
2005
39
0.100
Why?
Chromosomal Instability
1
2013
57
0.100
Why?
Lipoma
1
2013
24
0.100
Why?
Phosphoproteins
1
2015
420
0.100
Why?
Estrogen Receptor alpha
1
2016
458
0.100
Why?
Fibroma
1
2013
29
0.100
Why?
Multiplex Polymerase Chain Reaction
1
2012
29
0.100
Why?
Cells, Cultured
3
2017
3061
0.100
Why?
Mucin-4
1
2012
11
0.100
Why?
Brain Neoplasms
1
2022
1297
0.100
Why?
Cell Lineage
1
2014
355
0.100
Why?
Lymphocytes
1
2014
410
0.100
Why?
Exons
2
2012
800
0.100
Why?
Microsatellite Repeats
1
2013
222
0.100
Why?
Forkhead Box Protein O1
2
2009
90
0.100
Why?
Mass Screening
1
2018
787
0.100
Why?
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
2013
84
0.100
Why?
Magnetic Resonance Imaging
2
2014
3597
0.100
Why?
Atrophy
1
2012
231
0.100
Why?
Age Factors
2
2015
2831
0.100
Why?
Patched Receptors
1
2011
31
0.100
Why?
Adenocarcinoma
1
1999
1026
0.100
Why?
Tissue Fixation
1
2012
38
0.100
Why?
Patched-1 Receptor
1
2011
39
0.100
Why?
Genes, Neoplasm
1
2012
80
0.090
Why?
Cross Reactions
1
2012
192
0.090
Why?
Fibromatosis, Abdominal
1
2011
1
0.090
Why?
Mouth Neoplasms
1
2012
84
0.090
Why?
Alleles
1
2016
1617
0.090
Why?
Primary Myelofibrosis
1
2012
51
0.090
Why?
Hepatectomy
2
2023
112
0.090
Why?
Proto-Oncogene Protein c-fli-1
3
2008
13
0.090
Why?
Hematopoietic Stem Cell Transplantation
2
2017
1204
0.090
Why?
Rabbits
1
2012
718
0.090
Why?
Cysts
1
2012
101
0.090
Why?
Models, Biological
1
2016
1468
0.090
Why?
Severe Combined Immunodeficiency
1
2011
106
0.090
Why?
Nuclear Envelope
1
2011
17
0.090
Why?
Europe
1
2012
357
0.090
Why?
Ultrasonography
1
2015
941
0.090
Why?
Abdominal Neoplasms
1
2011
33
0.090
Why?
Enzyme Induction
1
2010
104
0.090
Why?
Neoplasm, Residual
2
2009
122
0.090
Why?
Myofibroblasts
1
2011
77
0.090
Why?
Signal Transduction
4
2019
4585
0.090
Why?
Lung Neoplasms
1
2020
1659
0.090
Why?
Proto-Oncogene Proteins c-mdm2
1
2010
80
0.090
Why?
Transcriptome
1
2016
973
0.080
Why?
Predictive Value of Tests
1
2015
2178
0.080
Why?
Protein-Tyrosine Kinases
1
2011
212
0.080
Why?
Recurrence
3
2025
1420
0.080
Why?
Transcription Factor HES-1
1
2009
19
0.080
Why?
Hepatocyte Nuclear Factor 4
1
2009
19
0.080
Why?
Insulin-Like Growth Factor II
1
2009
41
0.080
Why?
Myogenin
1
2008
10
0.080
Why?
Periodic Acid-Schiff Reaction
1
2008
3
0.080
Why?
Severity of Illness Index
1
2017
2918
0.080
Why?
Glycogen
1
2008
63
0.070
Why?
Mice, Nude
3
2020
717
0.070
Why?
Immunocompetence
1
2008
33
0.070
Why?
Proto-Oncogene Proteins c-myc
2
2020
201
0.070
Why?
Piperazines
1
2010
242
0.070
Why?
Molecular Targeted Therapy
1
2010
373
0.070
Why?
Chromosomes, Human, Pair 9
1
2008
108
0.070
Why?
Rhabdomyosarcoma, Embryonal
1
2008
51
0.070
Why?
Extremities
1
2008
83
0.070
Why?
Remission Induction
2
2019
300
0.070
Why?
Membrane Proteins
2
2020
1533
0.070
Why?
ErbB Receptors
1
2009
284
0.070
Why?
Histological Techniques
1
2007
22
0.070
Why?
Intercellular Signaling Peptides and Proteins
1
2009
284
0.070
Why?
Antineoplastic Agents
3
2019
1705
0.070
Why?
Neoplastic Stem Cells
1
2009
318
0.070
Why?
Lymphoma, Non-Hodgkin
2
2005
164
0.070
Why?
Skin
1
2010
519
0.070
Why?
Pyrimidines
1
2010
375
0.070
Why?
Syndrome
1
2009
1121
0.070
Why?
Uterine Neoplasms
1
2008
104
0.070
Why?
DNA Methylation
1
2013
1041
0.070
Why?
Antibodies, Monoclonal
1
2012
1033
0.060
Why?
Pediatrics
3
2024
1157
0.060
Why?
Basic Helix-Loop-Helix Transcription Factors
1
2009
393
0.060
Why?
Lymphoproliferative Disorders
2
1998
225
0.060
Why?
Disease Progression
3
2021
2089
0.060
Why?
Immunoglobulin lambda-Chains
1
2006
11
0.060
Why?
Poliovirus Vaccine, Inactivated
1
2005
12
0.060
Why?
Immunoglobulin kappa-Chains
1
2006
30
0.060
Why?
Survival Analysis
3
2016
1520
0.060
Why?
Genotype
1
2012
2568
0.060
Why?
Hashimoto Disease
1
2006
22
0.060
Why?
Homeodomain Proteins
1
2009
555
0.060
Why?
Ribonucleoproteins
2
1996
64
0.060
Why?
Hematopoietic Stem Cells
1
2009
543
0.060
Why?
Nuclear Proteins
3
2018
1273
0.060
Why?
Receptors, Purinergic P2Y
1
2025
6
0.060
Why?
Aged, 80 and over
3
2011
6607
0.060
Why?
Age of Onset
2
2020
601
0.060
Why?
Cell Proliferation
3
2020
2356
0.060
Why?
Chromosomes, Human, Pair 21
2
1996
40
0.060
Why?
Receptors, Cytokine
1
2025
68
0.060
Why?
Prospective Studies
3
2021
6171
0.060
Why?
Reproducibility of Results
1
2011
2899
0.060
Why?
Apoptosis
2
2022
1810
0.060
Why?
Cost Savings
1
2024
71
0.060
Why?
Liquid Biopsy
1
2024
14
0.060
Why?
Pathology, Molecular
1
2024
59
0.060
Why?
Lymphoma
2
2005
323
0.060
Why?
Breast Neoplasms
1
2016
2518
0.060
Why?
Fibrous Dysplasia of Bone
1
2003
7
0.060
Why?
Melanoma
2
2006
944
0.060
Why?
Coloring Agents
1
2024
77
0.060
Why?
Fibrous Dysplasia, Polyostotic
1
2003
7
0.050
Why?
Risk Assessment
3
2021
3470
0.050
Why?
Myxoma
1
2003
29
0.050
Why?
Tertiary Care Centers
1
2024
239
0.050
Why?
Chromosomes, Human, Pair 14
1
2024
102
0.050
Why?
Inflammation
1
2011
1447
0.050
Why?
Prevalence
1
2010
2467
0.050
Why?
Anemia, Iron-Deficiency
1
2006
136
0.050
Why?
Carcinogens
1
2023
152
0.050
Why?
Cell Adhesion Molecules, Neuronal
1
2003
78
0.050
Why?
Margins of Excision
1
2023
51
0.050
Why?
B-Lymphocytes
1
2006
534
0.050
Why?
HSP40 Heat-Shock Proteins
1
2022
22
0.050
Why?
Interleukin-6
1
2024
420
0.050
Why?
Extracellular Matrix Proteins
1
2003
157
0.050
Why?
Historiography
1
2002
2
0.050
Why?
State Medicine
1
2002
12
0.050
Why?
World Health Organization
1
2022
107
0.050
Why?
E2F6 Transcription Factor
1
2001
1
0.050
Why?
Activin Receptors
1
2001
14
0.050
Why?
Fourth Ventricle
1
2021
10
0.050
Why?
Biomarkers
1
2010
3095
0.050
Why?
B7-H1 Antigen
1
2022
120
0.050
Why?
Programmed Cell Death 1 Receptor
1
2022
128
0.050
Why?
Kaplan-Meier Estimate
3
2008
1075
0.050
Why?
Clinical Laboratory Techniques
1
2022
140
0.040
Why?
Cell Line
2
2016
2760
0.040
Why?
Ligands
1
2022
539
0.040
Why?
Brain Stem
1
2021
116
0.040
Why?
Inpatients
1
2024
500
0.040
Why?
Nucleotidyltransferases
1
2020
43
0.040
Why?
Cell Cycle
2
2015
619
0.040
Why?
Cerebral Cortex
1
2003
455
0.040
Why?
Hospitals, Pediatric
1
2024
766
0.040
Why?
Nerve Tissue Proteins
2
2003
1126
0.040
Why?
Transplantation, Heterologous
2
1997
260
0.040
Why?
Frozen Sections
1
1999
25
0.040
Why?
Heterogeneous-Nuclear Ribonucleoproteins
2
1996
24
0.040
Why?
Chromatin
1
2022
568
0.040
Why?
Proteasome Inhibitors
1
2019
60
0.040
Why?
Mice, 129 Strain
1
2019
98
0.040
Why?
Unfolded Protein Response
1
2019
62
0.040
Why?
Hypercalcemia
1
2018
39
0.040
Why?
Receptor, ErbB-2
1
2022
516
0.040
Why?
Granulosa Cell Tumor
1
2018
39
0.040
Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2019
103
0.040
Why?
Practice Patterns, Physicians'
1
2024
735
0.040
Why?
Loss of Heterozygosity
1
2018
129
0.040
Why?
Recombinant Fusion Proteins
3
1996
772
0.040
Why?
Proto-Oncogenes
1
1997
34
0.040
Why?
Genes, Retinoblastoma
1
1997
18
0.040
Why?
Codon, Nonsense
1
2018
131
0.040
Why?
Tissue Donors
2
1998
494
0.030
Why?
DNA Helicases
1
2018
235
0.030
Why?
Genes, p53
1
1997
215
0.030
Why?
Drug Therapy
1
2017
88
0.030
Why?
Molecular Motor Proteins
1
2016
29
0.030
Why?
International Agencies
1
2016
29
0.030
Why?
Gene Expression
2
2005
1561
0.030
Why?
Myosin Heavy Chains
1
2016
77
0.030
Why?
United States
1
2012
10942
0.030
Why?
Japan
1
2016
133
0.030
Why?
Heterozygote
1
2018
672
0.030
Why?
Delivery of Health Care
1
2002
616
0.030
Why?
Chromosome Deletion
1
2019
651
0.030
Why?
Germinal Center
2
2006
38
0.030
Why?
Ovary
1
2018
380
0.030
Why?
Nasal Mucosa
1
1996
66
0.030
Why?
Bone Marrow Transplantation
1
1998
575
0.030
Why?
Genome, Human
1
2022
1284
0.030
Why?
Stem Cell Transplantation
1
2017
239
0.030
Why?
Wnt Signaling Pathway
1
2016
193
0.030
Why?
Up-Regulation
2
2009
871
0.030
Why?
Tamoxifen
1
2016
363
0.030
Why?
Antineoplastic Agents, Hormonal
1
2016
257
0.030
Why?
Adenosine Triphosphate
1
2015
282
0.030
Why?
Proportional Hazards Models
2
2008
1365
0.030
Why?
Surveys and Questionnaires
1
2024
3745
0.030
Why?
RNA, Small Interfering
1
2016
667
0.030
Why?
Antigens, Surface
1
2014
117
0.030
Why?
DNA, Viral
2
2005
480
0.030
Why?
Los Angeles
1
2013
16
0.030
Why?
Immediate-Early Proteins
1
1994
58
0.030
Why?
Disseminated Intravascular Coagulation
1
2014
68
0.030
Why?
Axilla
1
2013
39
0.030
Why?
MutS Homolog 2 Protein
1
2013
39
0.030
Why?
MutL Protein Homolog 1
1
2013
53
0.030
Why?
Blotting, Western
1
2015
1108
0.030
Why?
S100 Proteins
1
2013
46
0.030
Why?
Neurons
1
2003
1940
0.030
Why?
Sequence Deletion
1
2015
527
0.030
Why?
Chromosomes, Human, Pair 15
1
2014
160
0.030
Why?
Incidence
1
2020
3155
0.020
Why?
Anemia, Myelophthisic
1
2012
2
0.020
Why?
Gene Expression Profiling
2
2010
1751
0.020
Why?
Bone Marrow Examination
1
2012
14
0.020
Why?
Reticulin
1
2012
8
0.020
Why?
Drug Resistance, Neoplasm
1
2016
733
0.020
Why?
Clone Cells
2
2006
168
0.020
Why?
DNA Repair-Deficiency Disorders
1
2011
4
0.020
Why?
Remission, Spontaneous
1
2012
69
0.020
Why?
Receptors, Thrombopoietin
1
2012
31
0.020
Why?
RNA, Messenger
3
2007
2824
0.020
Why?
Oligonucleotide Array Sequence Analysis
1
2015
1026
0.020
Why?
Splenomegaly
1
2012
33
0.020
Why?
Hepatitis C
1
2015
367
0.020
Why?
Adenosine Deaminase
1
2011
89
0.020
Why?
Staining and Labeling
1
2012
187
0.020
Why?
Antigens, CD
1
2013
432
0.020
Why?
Janus Kinase 2
1
2012
131
0.020
Why?
Eosinophilia
1
2012
101
0.020
Why?
Collagen
1
2012
320
0.020
Why?
Early Termination of Clinical Trials
1
2010
16
0.020
Why?
Imatinib Mesylate
1
2010
46
0.020
Why?
Clinical Trials, Phase II as Topic
1
2010
73
0.020
Why?
Adipose Tissue
1
2013
465
0.020
Why?
Mice, Inbred C57BL
1
2019
4416
0.020
Why?
Gene Expression Regulation, Enzymologic
1
2011
259
0.020
Why?
Benzamides
1
2010
109
0.020
Why?
Terminology as Topic
1
2011
223
0.020
Why?
PAX7 Transcription Factor
1
2008
17
0.020
Why?
MyoD Protein
1
2008
23
0.020
Why?
Hyaluronan Receptors
1
2008
66
0.020
Why?
Case-Control Studies
2
2005
3312
0.020
Why?
Epigenesis, Genetic
1
2013
697
0.020
Why?
Drug Administration Schedule
1
2010
729
0.020
Why?
Vulva
1
2008
16
0.020
Why?
Early Detection of Cancer
1
2011
362
0.020
Why?
Mutation, Missense
1
2012
878
0.020
Why?
Receptors, Notch
1
2009
205
0.020
Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2007
81
0.020
Why?
Regression Analysis
1
2008
781
0.020
Why?
Gene Expression Regulation
1
1995
2526
0.020
Why?
Gene Rearrangement, B-Lymphocyte, Heavy Chain
1
2006
4
0.020
Why?
Protein Kinase C
1
2007
149
0.020
Why?
Neprilysin
1
2006
19
0.020
Why?
Pseudolymphoma
1
2005
4
0.020
Why?
Costa Rica
1
2005
14
0.020
Why?
HIV Seronegativity
1
2005
26
0.020
Why?
Drug Contamination
1
2005
37
0.020
Why?
Genes, Viral
1
2005
185
0.020
Why?
Thyroid Gland
1
2006
104
0.010
Why?
Postoperative Complications
2
2012
3080
0.010
Why?
Lymphoma, B-Cell
1
2005
141
0.010
Why?
LDL-Receptor Related Proteins
1
2003
9
0.010
Why?
Receptors, Lipoprotein
1
2003
11
0.010
Why?
Mice, Neurologic Mutants
1
2003
74
0.010
Why?
Flow Cytometry
1
2006
801
0.010
Why?
Trisomy
1
2003
102
0.010
Why?
Nucleic Acid Hybridization
1
2003
396
0.010
Why?
Receptors, LDL
1
2003
88
0.010
Why?
History, 16th Century
1
2002
27
0.010
Why?
History, 17th Century
1
2002
35
0.010
Why?
Spain
1
2002
60
0.010
Why?
History, 18th Century
1
2002
70
0.010
Why?
HIV-1
1
2005
465
0.010
Why?
Comorbidity
1
2005
1537
0.010
Why?
Scalp
1
2000
57
0.010
Why?
Prednisone
1
2000
277
0.010
Why?
Vincristine
1
2000
193
0.010
Why?
Fetus
1
2003
587
0.010
Why?
Doxorubicin
1
2000
290
0.010
Why?
Transcription, Genetic
2
1995
1705
0.010
Why?
Y Chromosome
1
1998
47
0.010
Why?
Cyclophosphamide
1
2000
418
0.010
Why?
Viral Matrix Proteins
1
1998
109
0.010
Why?
Phosphopyruvate Hydratase
1
1998
31
0.010
Why?
Forearm
1
1998
45
0.010
Why?
Polymorphism, Single-Stranded Conformational
1
1997
70
0.010
Why?
Immunoenzyme Techniques
1
1998
258
0.010
Why?
Sex Chromosomes
1
1997
34
0.010
Why?
X Chromosome
1
1998
338
0.010
Why?
Fragile X Mental Retardation Protein
1
1998
124
0.010
Why?
Liver Failure
1
1997
89
0.010
Why?
In Situ Hybridization
1
1997
471
0.010
Why?
Kidney
1
2003
1369
0.010
Why?
RNA, Viral
1
1998
538
0.010
Why?
Activating Transcription Factor 1
1
1995
4
0.010
Why?
Transplantation, Homologous
1
1997
667
0.010
Why?
Mice, Inbred BALB C
1
1997
1000
0.010
Why?
Oligodeoxyribonucleotides
1
1995
135
0.010
Why?
Retroviridae Proteins, Oncogenic
1
1994
12
0.010
Why?
Precipitin Tests
1
1994
155
0.010
Why?
Reoperation
1
1997
834
0.010
Why?
Early Growth Response Protein 1
1
1994
37
0.010
Why?
In Vitro Techniques
1
1995
983
0.010
Why?
Chromosome Disorders
1
1995
311
0.010
Why?
Cloning, Molecular
1
1994
897
0.010
Why?
Recombinant Proteins
1
1995
1410
0.010
Why?
Amino Acid Sequence
1
1994
2714
0.010
Why?
HIV Infections
1
2000
1899
0.000
Why?
LOPEZ-TERRADA's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (621)
Explore
_
Co-Authors (105)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_